Ketamine works for depression by targeting the glutamate system rather than the serotonin or norepinephrine systems that conventional antidepressants act on. It works by blocking certain brain signals and helping nerve cells form new connections, and may quickly improve mood. Where SSRIs typically take four to eight weeks to produce noticeable improvement, ketamine can alleviate suicidal thoughts within just one to two hours of initiating an infusion a timeline unlike any other treatment currently available for depression. This guide explains the science behind why ketamine works, who it is appropriate for, what the treatment process involves, and what questions to ask before deciding whether it is right for you.
Medical note: Ketamine therapy is a prescription medical treatment administered under clinical supervision. This article is for informational purposes only and does not constitute medical advice. Whether ketamine therapy is appropriate for your specific situation requires evaluation by a qualified psychiatric provider.
Why Ketamine Is Different From Every Other Antidepressant
To understand why ketamine works differently, it helps to understand why conventional antidepressants work the way they do and where they fall short.
Standard antidepressants SSRIs, SNRIs, and most other medications prescribed for depression primarily act on the monoamine neurotransmitter systems: serotonin, norepinephrine, and dopamine. The standard medical care for depression over the past 50 years has focused on monoamine neurotransmitters, and these treatments can take weeks to take effect. For many people, they are effective. For a significant number, they are not either because the medication does not produce adequate improvement, because side effects are not tolerable, or because repeated trials of different medications have not led to meaningful relief.
This is the population ketamine was initially studied in: people with treatment-resistant depression, for whom the standard toolkit had not worked. What researchers found was not just a new drug that worked on the same system, it was a drug that worked on an entirely different system, through an entirely different mechanism, and produced results on an entirely different timeline.
Ketamine targets a different system in the brain than typical antidepressants, and that may be why ketamine works so well, even for patients who have not had success with different standard antidepressants.
The Science: What Ketamine Does in the Brain
Blocking NMDA Receptors
Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist that rapidly reduces suicidal ideations and depressive symptoms.
NMDA receptors are proteins on the surface of neurons that regulate how brain cells respond to glutamate, the brain’s primary excitatory neurotransmitter. In depression, the NMDA receptor system becomes dysregulated: glutamate signalling is disrupted, synaptic communication becomes less efficient, and the brain’s capacity for neuroplasticity and its ability to form new connections and adapt diminishes.
When ketamine blocks NMDA receptors, it interrupts this dysregulated signalling pattern. But blocking NMDA receptors is not the end of the story, it is the beginning of a cascade.
The Glutamate Surge and AMPA Receptor Activation
When ketamine blocks NMDA receptors, the result is a rapid increase in available glutamate, which then activates a different class of AMPA receptors. Increased glutamate activates AMPA receptors, triggering crucial downstream cascades, including BDNF-TrkB and mTOR pathways, promoting synaptic proliferation and regeneration.
This is the mechanistic heart of ketamine’s antidepressant effect. The activation of AMPA receptors triggers a chain reaction that ultimately stimulates the growth and regeneration of synapses and the connections between neurons. Researchers tracked changes in a critical brain receptor that helps neurons communicate and found that ketamine reshapes its activity in specific brain regions tied to mood and reward, and these shifts strongly matched improvements in patients’ symptoms.
Synaptogenesis Rebuilding the Brain’s Connections
In depression, synaptic connections in regions of the brain involved in mood regulation including the prefrontal cortex and the hippocampus are reduced. Chronic stress and sustained depression literally shrink the density of these connections. This is not metaphorical. It is a structural change that can be measured.
Ketamine seems to allow for a regrowth of synapses connections between neurons, explains John Krystal, MD, chair of the Yale School of Medicine Department of Psychiatry.
Increased neuronal dendritic growth may contribute to synaptogenesis and an increase in brain-derived neurotrophic factor (BDNF). BDNF is sometimes described as “fertilizer for the brain” ; it promotes the survival, growth, and differentiation of neurons. In depression, BDNF levels are often reduced. Ketamine rapidly increases BDNF, which supports the restoration of the synaptic density that depression has reduced.
The Neuroplasticity Window
There is evidence that ketamine can have a very rapid onset of effects in neuroplasticity “we think this may open a critical period in which the brain is more plastic, both at the cellular level and possibly even at the functional level,” according to Gerard Sanacora, MD, PhD, director of the Yale Depression Research Center.
This neuroplasticity window, a period of enhanced brain adaptability following ketamine treatment, is one of the reasons why combining ketamine therapy with psychotherapy is increasingly standard in clinical practice. The brain is more receptive to new patterns of thought and new cognitive approaches in the period following treatment, which makes the therapeutic work more accessible and potentially more durable.
Effects on Brain Networks
Neuroimaging studies have demonstrated alterations in brain networks involved in emotional regulation, including the Default Mode Network, the Central Executive Network, and the Salience Network, which are frequently disrupted in depression.
The Default Mode Network active when the mind is at rest and producing self-referential thinking is overactive in depression, contributing to the rumination and negative self-focus that characterises the condition. Ketamine modulates this network’s activity, which may partly explain the shift in perspective and sense of psychological relief that many patients describe during and after treatment.
How Quickly Does Ketamine Work?
This is the feature of ketamine therapy that most distinguishes it from everything else in the depression treatment toolkit.
Antidepressant effects begin approximately two hours post-infusion after acute dissociative and euphoric side effects subside and continue far beyond the drug’s elimination half-life of 2.5 — 3 hours.
At sub-anaesthetic doses, a single infusion of ketamine can elicit a rapid, though transient, antidepressant response.
For context: a standard SSRI takes four to six weeks to begin producing noticeable improvement, and the full therapeutic benefit often develops over eight to twelve weeks. Ketamine produces measurable improvement within hours. For someone in severe depression, or with active suicidal ideation, this timeline is not just clinically significant it can be life-changing.
The trade-off is that the effect from a single infusion is typically transient lasting days to weeks rather than indefinitely. This is why ketamine therapy is almost always delivered as a series of sessions rather than a single treatment, and why it is often combined with ongoing psychotherapy or medication management to support and extend the benefit.
Who Ketamine Therapy Is Designed For
Ketamine therapy is not a first-line treatment for depression; it is primarily used when other approaches have not been sufficient. The clearest candidates include:
Treatment-resistant depression: People who have tried two or more antidepressant medications at adequate doses without achieving meaningful improvement. When at least two trials of a standard anti-depression medication fail to alleviate symptoms, ketamine treatment may be an option.
Depression with active suicidal ideation: Ketamine can alleviate suicidal thoughts within just one to two hours of initiating the infusion, offering a crucial lifeline for individuals with major depressive disorder at high risk of suicide. No other currently available treatment matches this timeline for suicidality reduction.
Depression with urgent need for rapid response: Situations where the timeline of standard antidepressant treatment weeks to months is not appropriate given the severity of current symptoms.
People who cannot tolerate standard antidepressants: Side effects from SSRIs and SNRIs lead many people to discontinue medication before achieving adequate trials. For people in this situation, ketamine offers an entirely different pharmacological route.
Ketamine therapy is not appropriate for everyone, and a clinical evaluation is required before treatment begins. Conditions that may affect candidacy include uncontrolled high blood pressure, a personal or family history of psychosis or schizophrenia, active substance use disorders, and certain other medical conditions. our post on How ketamine therapy Works
How Ketamine Therapy Is Administered
There are several methods of ketamine administration, each with different clinical profiles:
Intravenous (IV) Infusion
IV infusion is the most studied and most precise method of ketamine administration for depression. Most published trials using ketamine as an antidepressant have used similar low sub-anaesthetic doses of 0.5mg/kg and the same route of administration a single slow intravenous infusion over 40 minutes.
IV administration allows the dose to be controlled precisely and adjusted in real time, and produces the most consistent and well-characterised antidepressant effects. It requires clinical supervision throughout the infusion.
Intranasal Esketamine (Spravato)
Esketamine (brand name Spravato) is a nasal spray form of a ketamine derivative approved by the FDA specifically for treatment-resistant depression and for major depressive disorder with suicidal ideation. It is administered in a clinical setting under supervision and represents the only FDA-approved ketamine-derived treatment for depression.
Esketamine acts on the same general mechanisms as IV ketamine but with some pharmacological differences. It is the version most commonly covered by insurance when coverage applies which is covered in our upcoming post on ketamine therapy cost and insurance coverage.
Intramuscular (IM) Injection
IM injection is another supervised administration route. It is less precisely titratable than IV but requires less infrastructure and is used by some clinical providers. Onset is slightly slower than IV administration.
Oral Ketamine
Oral ketamine is available and used in some clinical contexts, but it has lower bioavailability than other routes meaning a smaller proportion of the dose reaches the bloodstream and is generally considered less established for depression treatment specifically.
What a Typical Treatment Course Looks Like
Ketamine therapy for depression is almost never a single session. A typical treatment course involves:
Initial series: Most protocols involve six infusions administered over two to three weeks often three sessions per week. This series is designed to establish a therapeutic response and build on the neuroplasticity effects of each session.
Response assessment: After the initial series, the treatment team evaluates how you have responded. Many people experience significant improvement during or immediately after the series. The assessment guides what comes next.
Maintenance sessions: Some people maintain their response with periodic booster sessions monthly, every six weeks, or as needed based on how long improvement persists. The maintenance schedule is individual and developed in collaboration with your provider.
Integration with therapy and medication: Ketamine is most effective when it is part of a broader treatment plan. Yale experts talk about how ketamine can work with a comprehensive treatment plan that includes psychotherapy, such as cognitive behavioural therapy (CBT). The neuroplasticity window ketamine creates is an opportunity psychotherapy during and after the ketamine series can help consolidate the changes and extend the benefit.
What People Actually Experience During Treatment
The experience during a ketamine infusion varies between people and between sessions, but common descriptions include:
A sense of dissociation or detachment, the feeling of being slightly removed from normal consciousness. This is expected and temporary, resolving as the infusion ends and for a short period afterward.
Visual or perceptual changes colours or shapes may appear more vivid, or the sense of spatial depth may feel altered.
A feeling of relaxation or calm that some people describe as unlike anything they experience in ordinary waking life.
Some people find the dissociative experience disorienting or uncomfortable, particularly in the first session. This is why ketamine therapy is always administered in a monitored clinical environment, not at home, and why having a provider present throughout is standard.
The acute effects of the infusion resolve within hours. Antidepressant effects begin approximately two hours post-infusion after acute dissociative and euphoric side effects subside. You will not be in a dissociative state when the antidepressant effect is active; the therapeutic effect emerges as the immediate experience resolves.
You will need someone to drive you home after each session. You should not drive or make significant decisions on the day of treatment.
How Long the Effects Last
This is one of the most important practical questions, and one that deserves an honest answer.
A single infusion typically produces improvement lasting days to approximately two weeks. The initial series of infusions tends to produce a more sustained response weeks to months for many people. A subset of patients experience durable remission from the initial series alone. Others find that periodic maintenance sessions are needed to sustain the benefit.
The variability is real. Ketamine is not a permanent fix for everyone, and going in with realistic expectations about the likely need for maintenance is part of making an informed decision. Your provider can give you a clearer picture of what the evidence suggests for your specific clinical situation based on the evaluation.
Ketamine vs. Standard Antidepressants: How They Compare
| Feature | SSRIs / SNRIs | Ketamine Therapy |
| Mechanism | Serotonin / norepinephrine system | Glutamate system (NMDA, AMPA) |
| Onset of effect | 4–8 weeks typically | Hours to days |
| Administration | Daily oral medication | Supervised clinical sessions |
| Best suited for | First and second-line depression treatment | Treatment-resistant depression; rapid response needed |
| Duration of effect | Sustained with continued use | Variable; may require maintenance sessions |
| FDA approval status | Approved for depression | IV ketamine: off-label; Esketamine (Spravato): FDA-approved |
| Insurance coverage | Generally covered | Variable; esketamine better covered than IV |
FAQs
How does ketamine therapy work for depression?
Ketamine therapy works by blocking certain brain signals and helping nerve cells form new connections. Specifically, it blocks NMDA glutamate receptors, which triggers a cascade that increases BDNF, activates AMPA receptors, and promotes the growth of new synaptic connections in brain regions involved in mood regulation. Unlike SSRIs, which target the serotonin system and take weeks to work, ketamine produces antidepressant effects within hours through an entirely different mechanism.
How quickly does ketamine therapy work?
Ketamine can alleviate suicidal thoughts within just one to two hours of initiating an infusion. Most people notice meaningful improvement within hours to days of their first infusion a timeline unlike any other available antidepressant. Antidepressant effects begin approximately two hours post-infusion, after acute dissociative effects subside.
Is ketamine therapy only for treatment-resistant depression?
It is most commonly used for treatment-resistant depression when at least two trials of a standard anti-depression medication fail to alleviate symptoms, ketamine treatment may be an option. It is also used when rapid response is clinically needed, such as in severe depression with active suicidal ideation. Whether ketamine is appropriate for your situation requires an evaluation with a psychiatric provider.
How many ketamine sessions are needed?
A typical initial course involves six infusions over two to three weeks. Some people achieve sustained remission from the initial series. Others benefit from periodic maintenance sessions to sustain improvement. The maintenance schedule is individual and developed in collaboration with your provider based on how you respond.
What does ketamine therapy feel like?
During an infusion, most people experience some degree of dissociation, a sense of detachment from normal consciousness along with possible perceptual changes. These effects are temporary and resolve as the infusion ends and during the brief recovery period afterward. The antidepressant effect is not experienced during the infusion itself but emerges in the hours and days following.
Does ketamine therapy work if antidepressants have not?
For many people, yes. Ketamine targets a different system in the brain than typical antidepressants, and that may be why ketamine works so well, even for patients who have not had success with different standard antidepressants. Because it acts on the glutamate system rather than the monoamine system that SSRIs target, prior failure with antidepressants does not predict failure with ketamine.
How long do the effects of ketamine therapy last?
A single infusion typically produces improvement lasting days to approximately two weeks. The initial series of infusions tends to produce more sustained improvement weeks to months for many people. Some patients experience durable remission; others find periodic maintenance sessions are needed. Your provider can give you a clearer picture based on your clinical evaluation.
Is ketamine therapy safe?
Ketamine therapy administered under proper clinical supervision has a well-characterised safety profile. Safety considerations, side effects, and who is and is not a good candidate.
Is Ketamine Therapy Worth Considering?
For people who have been through multiple antidepressant trials without adequate relief, or who are experiencing severe depression that standard timelines cannot address, ketamine therapy offers something genuinely different: a different mechanism, a different timeline, and in many cases, a meaningful response where nothing else has worked.
It is not a universal solution, and it requires honest evaluation of candidacy, realistic expectations about maintenance, and integration with a broader treatment plan. But for the right person, it represents one of the most significant developments in depression treatment in decades.
If you are in Allen, TX or Sherman, TX and want to explore whether ketamine therapy is appropriate for your situation, our team at Premier Psychiatry offers evaluation and ketamine therapy as part of a comprehensive psychiatric care approach. Visit our Ketamine Therapy page to learn more, or contact us to schedule an initial evaluation.
Medical Disclaimer: The information in this article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding your individual health concerns.
